Lv62
2160 积分 2024-12-12 加入
Biomarkers for immunotherapy of hepatocellular carcinoma
16天前
已完结
Radiofrequency Thermal Ablation for Hepatocellular Carcinoma Stimulates Autologous NK-Cell Response
16天前
已关闭
Relationship between SUVmax on 18F-FDG PET and PD-L1 expression in hepatocellular carcinoma
16天前
已完结
The impact of PD-L1 as a biomarker of cancer responses to combo anti-PD-1/CTLA-4
16天前
已完结
Liver resection after atezolizumab and bevacizumab versus maintenance therapy for locally advanced hepatocellular carcinoma (TALENTOP): a multicentre, open-label, randomised, phase 3 trial
1个月前
已完结
Neoadjuvant GOLP in Resectable High-Risk Intrahepatic Cholangiocarcinoma
1个月前
已完结
Phase I results of a multicenter, open-label, dose de-escalation and expansion study of gemcitabine and cisplatin with ivosidenib or pemigatinib for advanced cholangiocarcinoma
1个月前
已完结
Claudin-18.2 in Gastric and Gastroesophageal Junction Adenocarcinoma: From Biology to Therapeutic Targeting: A Narrative Review
1个月前
已完结
Precision targeting of CLDN18.2: A new therapeutic paradigm for gastric cancer
1个月前
已完结
Targeting claudin 18.2 in gastric cancer: a review of emerging biologic agents
1个月前
已完结
皖公网安备34019202002308
